INVACongressional Stock Trades
Innoviva, Inc. Common Stock
Pharmaceutical Preparations
Congressional stock trades in Innoviva, Inc. Common Stock (INVA) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
2
Politicians Trading
1
Last Traded
Mar 25, 2025
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| George WhitesidesD | Apr 23, 2025 | Mar 25, 2025 | Sell | $250,001 - $500,000 | +20.43% |
| George WhitesidesD | Apr 23, 2025 | Mar 24, 2025 | Sell | $50,001 - $100,000 | +20.77% |
Price History
About Innoviva, Inc. Common Stock
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
1 members of Congress have disclosed 2 trades in Innoviva, Inc. Common Stock (INVA). Most active: George Whitesides (2).
Across all disclosures, members of Congress reported 0 purchases and 2 sales of Innoviva, Inc. Common Stock (INVA). The most recent trade was on Mar 25, 2025.
George Whitesides disclosed selling Innoviva, Inc. Common Stock (INVA) on Mar 25, 2025, valued at $250,001 - $500,000.
From House and Senate periodic transaction reports filed under the STOCK Act. Members of Congress must disclose trades within 45 days, and amounts are reported as ranges, not exact values.